Clinical Trial Update: Long-term Safety Study of BHV-7000 in Participants With Major Depressive Disorder (MDD) [Phase 2]

View source ↗

Summary

Phase 2 long-term safety study of BHV-7000 in adults with Major Depressive Disorder completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• BHV-7000

Snippet

Sponsor: Biohaven Therapeutics Ltd. | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED